ArticleNoro psikiyatri arsivi2022
Is Two-Point Discrimination Test a New Diagnostic Method for the Diagnosis of Fibromyalgia?
Article in Noro psikiyatri arsivi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 2 citations in OpenAlex.
- The Neutrophil-to-Lymphocyte Ratio in Fibromyalgia: A Systematic Review with a Neuroimmune Perspective.Brain sciences · 2026Review
- Elevated Monocyte-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Are Associated with Disease Activity and Pain in Fibromyalgia: A Cross-Sectional Study.Journal of clinical medicine · 2025Article
- Visuotactile integration in individuals with fibromyalgia.Frontiers in human neuroscience · 2024Article
- Brain morphometric changes in fibromyalgia and the impact of psychometric and clinical factors: a volumetric and diffusion-tensor imaging study.Arthritis research & therapy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fibromyalgia is a syndrome of obscure pathogenesis without objective diagnostic criteria and is frequently associated with diagnostic delays due to symptomatic heterogeneity. This study aimed at assessing the response to two-point discrimination test in extremities, neutrophil/lymphocyte ratio (NLR), Numeric Rating Scale (NRS) score, and Widespread Pain Index (WPI) score in patients with fibromyalgia. Methods: The patient group consisted of 26 subjects diagnosed with fibromyalgia based on the 2016 revision to the American College of Rheumatology 2010 diagnostic criteria, while 25 healthy individuals comprised the control group. In both groups, basal amplitude and somatosensorial temporal discrimination (STD) measurements at the dorsum of the hands and feet were performed in addition to NLR measurements. Also, NRS and WPI were determined in fibromyalgia patients. Results: STD was significantly prolonged in all extremities among fibromyalgia patients as compared to controls. WPI and NRS were also increased, paralleling the STD measurements in all extremities (p<0.05). NLR was higher in the patient group than in controls, although the difference was insignificant. Conclusion: STD values were high in fibromyalgia patients. So, STD appears to have a potential role as an auxiliary diagnostic tool in fibromyalgia. Still, further studies are needed to support this conclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.